SCHEMBL5312679

SCHEMBL5312679

CCOC(=O)CNc1c(C)cc(C)cc1C

nearest known ligand 0.63

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
NLRP3 Q96P20 4/20 0.59
POLB P06746 1/20 0.44
SMN1; SMN2 Q16637 3/20 0.44
GAA P10253 2/20 0.43
MGAM O43451 1/20 0.43
SI P14410 1/20 0.43
MGAM2 Q2M2H8 1/20 0.43
TSHR P16473 2/20 0.42
LMNA P02545 2/20 0.42
ALDH1A1 P00352 2/20 0.42
MAPT P10636 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
HPGD P15428 1/20 0.41
TP53 P04637 1/20 0.40
HSD17B10 Q99714 1/20 0.40
PPID Q08752 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15516425 0.85 NLRP3 (0.46) NLRP3POLBGAATSHRLMNA
SCHEMBL9829734 0.83 NLRP3 (0.56) NLRP3POLBSMN1; SMN2GAAMGAM
SCHEMBL11136294 0.82 NLRP3 (0.59) NLRP3POLBGAAMGAMSI
SCHEMBL27974053 0.80 POLB (0.53) NLRP3POLBSMN1; SMN2GAAMGAM
SCHEMBL11261924 0.80 POLB (0.50) NLRP3POLBSMN1; SMN2LMNAALDH1A1
SCHEMBL11263310 0.79 L3MBTL1 (0.49) NLRP3POLBSMN1; SMN2LMNAALDH1A1
SCHEMBL11267589 0.79 L3MBTL1 (0.43) NLRP3POLBSMN1; SMN2GAALMNA
SCHEMBL11277397 0.78 L3MBTL1 (0.45) NLRP3POLBSMN1; SMN2LMNAALDH1A1
SCHEMBL1932411 0.77 HPGD (0.47) NLRP3POLBSMN1; SMN2TSHRLMNA
Hydrochloric Acid SCHEMBL14988832 0.77 LMNA (0.52) NLRP3POLBSMN1; SMN2TSHRLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1730117-B1 THIOUREA COMPOSITIONS AND USES THEREOF UNIV HONG KONG (CN) 2015-12-02 EP disclosed
US-20150267232-A1 IN VIVO AND IN VITRO CARBENE INSERTION AND NITRENE TRANSFER REACTIONS CATALYZED BY HEME ENZYMES CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 2015-09-24 US disclosed
US-7501510-B2 Thiourea compositions and uses thereof THE UNIVERSITY OF HONG KONG (CN) 2009-03-10 US disclosed
US-7501510-B2 Thiourea compositions and uses thereof THE UNIVERSITY OF HONG KONG (CN) 2009-03-10 US disclosed
US-20070112015-A1 Substituted dihydropyridines and methods of use CHEMOCENTRYX, INC. (US) 2007-05-17 US disclosed
US-20070112015-A1 Substituted dihydropyridines and methods of use CHEMOCENTRYX, INC. (US) 2007-05-17 US disclosed
US-20070112015-A1 Substituted dihydropyridines and methods of use CHEMOCENTRYX, INC. (US) 2007-05-17 US disclosed
WO-2007051062-A2 SUBSTITUTED DIHYDROPYRIDINES AND METHODS OF USE CHEMOCENTRYX, INC. (US) 2007-05-03 WO disclosed
WO-2007051062-A2 SUBSTITUTED DIHYDROPYRIDINES AND METHODS OF USE CHEMOCENTRYX, INC. (US) 2007-05-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070112015-A1 Substituted dihydropyridines and methods of use C3AR1, C5AR1, C5AR2 NLRP3 756/4885POLB 3870/4885SMN1; SMN2 2580/4885
US-20150267232-A1 IN VIVO AND IN VITRO CARBENE INSERTION AND NITRENE TRANSFER REACTIONS CATALYZED BY HEME ENZYMES HMBS, HMOX1, HMOX2 NLRP3 3521/4885POLB 1288/4885SMN1; SMN2 3363/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.